NCT01318252View on ClinicalTrials.gov

AL-54478 Proof of Concept Study

PHASE2CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Open-angle Glaucoma (OAG)Ocular Hypertension (OHT)

Interventions

DRUG

AL-54478 0.005%

DRUG

Latanoprost 0.005%

DRUG

AL-54478 Vehicle

Inactive ingredients used as a placebo comparator

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY